Goodwin, S D, Sproat, T T, Russell, W L · Clinical pharmacy · 1990
Quick Summary
This review examines Lyme disease, a tick-borne infection caused by a bacterium called Borrelia burgdorferi. The disease has three stages: early flu-like illness with a rash, middle-stage problems affecting the nervous system and heart, and late-stage arthritis or chronic fatigue. Treatment with antibiotics like doxycycline is most effective when started early.
Why It Matters
This study is relevant to ME/CFS research because it documents that Lyme disease can present with a chronic fatigue syndrome phenotype in its third stage, helping researchers distinguish Lyme-associated fatigue from primary ME/CFS. Understanding the relationship between tick-borne infections and fatigue syndromes is important for accurate diagnosis and differential diagnosis in ME/CFS populations.
Observed Findings
Lyme disease presents in three clinical stages with progressive manifestations
Stage III can include arthritis, multiple sclerosis-like syndrome, psychiatric disorders, and chronic fatigue syndrome
Tetracycline and doxycycline are more effective than penicillin for preventing late Lyme disease
Ceftriaxone is considered the preferred agent for treating late-stage Lyme disease
Treatment duration for early disease ranges from 10 days to three weeks
Inferred Conclusions
Early antibiotic treatment with tetracycline or doxycycline significantly improves outcomes and prevents disease progression
Both infectious and immunologic mechanisms contribute to Lyme pathogenesis, though infectious mechanisms are considered primary
Chronic fatigue syndrome can be a manifestation of untreated or inadequately treated Lyme disease
Optimal antibiotic treatment protocols for late-stage Lyme disease and Lyme arthritis require further study
Remaining Questions
What is the optimal duration and choice of antibiotic for Lyme arthritis specifically?
What This Study Does Not Prove
This review does not prove that ME/CFS is caused by Lyme disease or that most ME/CFS patients have undiagnosed Lyme infection. It does not establish the prevalence of Lyme-associated fatigue syndrome versus primary ME/CFS, nor does it provide mechanistic evidence for how Borrelia burgdorferi causes chronic fatigue symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →